Angela Kazan

Angela Kazan is an experienced professional in pharmacovigilance and safety management, currently serving as Associate Director and Senior Manager at Cidara Therapeutics since January 2019. Angela's expertise includes overseeing SAE and SUSAR tracking, unblinded pharmacovigilance, and regulatory submissions to the FDA. Previous roles include Drug Safety Consultant at ICON plc, managing SAE processing and leading projects, and Manager of Aggregate Reports at Valeant Pharmaceuticals, where Angela focused on compiling adverse drug experience reports. Angela's earlier positions include a quality review role at Merck & Company Inc and clinical nursing experience in critical care at Lehigh Valley Health Network and UPMC. Angela holds a Bachelor of Science in Nursing from the University of Pittsburgh and a Health Care Compliance certificate from the University of Pittsburgh School of Law.